Product Name:

NebuSelect™ Recombinant Human SLAMF7/CRACC/CD319, 1-226aa, His-tag

Catalog#:

NBL-230048

Description:

NebuSelect™ Recombinant Human SLAMF7/CRACC/CD319, 1-226aa, His-tag(Cat#NBL-230048) is expressed in HEK293 with His tag at the C-Terminus. It contains Met1-Met226 aa.

Species:

Human

Expression System:

HEK293

Molecular Weight: 

The protein has a predicted MW of 24 kDa

Target Name:

SLAMF7/CRACC/CD319; CD2 subset 1; CRACC; Novel Ly9; CD319; SLAMF7; CS1; 19A; FOAP-12

Target Information:

CD2-like receptor activating cytotoxic cells (CRACC), also known as CS1, novel Ly9, SLAMF7, and CD319, is a 65-75 kDa type I transmembrane glycoprotein in the SLAM subgroup of the CD2 family.Self-ligand receptor of the signaling lymphocytic activation molecule (SLAM) family. SLAM receptors triggered by homo- or heterotypic cell-cell interactions are modulating the activation and differentiation of a wide variety of immune cells and thus are involved in the regulation and interconnection of both innate and adaptive immune response.

Amino Acid Sequence: 

Ser23-Met226

Purity:

＞95%

Formulation:

see COA

Endotoxin:

＜1EU/ug(LAL Method)

Storage: 

4°C for short term. 

-20°C for long term.

To get more information, please contact us freely.